Seattle, WA, United States of America

James Christopher McInnes

This inventor holds 9 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: L'oreal, Optiva, Inc., Ultreo, Inc.. Active years: 1998-2019.

USPTO Granted Patents = 9 

% Patents Active = 77.8

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 645(Granted Patents)


Company Filing History:


Years Active: 1998-2019

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of James Christopher McInnes

Introduction: James Christopher McInnes is a visionary inventor based in Seattle, Washington. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of technology through his inventive spirit and dedication.

Latest Patents: James Christopher McInnes holds several patents in various technological domains, including artificial intelligence, renewable energy, and healthcare devices. His recent patents focus on enhancing user experiences through innovative design and functionality.

Career Highlights: Throughout his career, James Christopher McInnes has been recognized for his innovative approach to problem-solving. He has received numerous awards for his contributions to the tech industry and has been instrumental in driving forward-thinking initiatives.

Collaborations: James Christopher McInnes has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work across disciplines and industries has led to successful partnerships that have resulted in groundbreaking innovations.

Conclusion: James Christopher McInnes continues to push the boundaries of technology with his inventive mindset and collaborative spirit. His passion for creating solutions that make a difference in people's lives sets him apart as a true innovator in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…